Impact factors for perioperative and long-term outcome of ovarian cancer patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00036911

Enrollment

763

Registered

2025-05-14

Start date

2021-06-09

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C56

Interventions

Group 1: Retrospective observational study in the cohort of ovarian cancer patients treated between 2006 and 2021 at the Department of Gynaecology of Jena University Hospital. Possible relations betwe

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Suspected ovarian, tubal or peritoneal cancer, Treatment at the Department of Gynaecology of Jena University Hospital

Exclusion criteria

Exclusion criteria: No primary case, malign diagnosis or histology not confirmed

Design outcomes

Primary

Measure	Time frame
Recurrence of disease or death after completion of primary treatment	—

Secondary

Measure	Time frame
Major complications within 30 days after primary cytoreductive surgery	—

Countries

Germany

Contacts

Public ContactIngo B. Runnebaum

Klinik und Poliklinik für Frauenheilkunde und Fortpflanzungsmedizin des Universitätsklinikums Jena

ingo.runnebaum@med.uni-jena.de+4936419329133

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026